With a 300% increase in urgent suspected skin cancer referrals since 2010 and 45-50 patients seen per day at the Skin Cancer Centre in Amersham Hospital, Buckinghamshire Healthcare NHS Trust implements DERM to address their increasing dermatology demand.
Chelsea and Westminster Hospital NHS Foundation Trust (CWFT) and NHS Suffolk and North East Essex Integrated Care Board (SNEE) have been shortlisted for the HSJ Awards 2024, recognising an outstanding contribution to healthcare and securing a place at the prestigious awards ceremony later this year.
Last month, Alastair Fee, reporter at the BBC, visited UHD’s dermatology department at Christchurch to see how our AI as a medical device is being used to drive quicker access to skin cancer diagnosis for patients in the locality and reduce waiting times.
Tameside and Glossop Integrated Care NHS Foundation Trust are a General Manchester based trust who are opening their doors again to urgent suspected skin cancer referrals – only this time the post-referral service will use AI Teledermatology.
Manchester University NHS Foundation Trust launches a post-referral service for suspected skin cancer with Skin Analytics.
People passionate about building a world where no one dies from skin cancer, all in one room at the Skin Analytics Customer Conference!
By leveraging our AI medical device, DERM, within UHD’s post-referral pathway, we will look to address the gap between demand and capacity so the Trust’s dermatologists can spend precious time on patients who need them most.
With extremely limited dermatology capacity resulting in all Trust resources consumed by efforts to meet FDS targets, this AI powered pathway will remove the need to see patients with benign lesions face-to-face and reserve Dorset County Hospital’s dermatology capacity for patients with skin cancer.
Rishi Sunak and Skin Analytics were invited to a meet and greet at Woking Community Hospital to see the work being delivered at Woking Community Centre’s Diagnostic Hub.
LUHFT are one of the additional nine NHS trusts awarded funding to pilot DERM, and their patients in the Sefton area will be first out of approximately 45,000 patients to benefit from our technology by the summer – when skin cancer referrals are at their highest.
An additional nine NHS trusts have been funded to pilot Skin Analytics’ AI medical device to detect cancerous skin lesions, with around 45,000 patients benefiting from this groundbreaking technology by the summer when skin cancer referrals are at their highest.
Vitality Health has recently launched an online GP service for UK customers and we are proud to announce that a Skin Analytics skin check is now part of their suite of diagnostic tests.
